Back to results

Università degli studi di Trento

A eukaryotic platform for the enhancement of Cas nucleases

Abstract

dc:description

A large repertoire of CRISPR-Cas systems from bacteria, archaea and phages is available for a large variety of genome editing applications. Nevertheless, a limited number of orthologs have the same editing efficiency as SpCas9 in mammalian cells. Moreover, Cas with reduced molecular size that have been characterized and could give an advantage in delivery, are poorly active in human cells. Directed evolution was proved as a valid approach to identify Cas proteins with altered functions, however unbiased screenings to enhance Cas nucleases have been described only in bacterial cells. Here we develop a fully eukaryotic platform to evolve inefficient Cas proteins toward highly active nucleases. A first step of directed evolution is performed in yeast to isolate enhanced variants by auxotrophic selection; a further screening of the mutants directly in mammalian cells is achieved through a fluorescence activation system. We have first applied the platform to the smallest Type II Cas9 ortholog, CjCas9 (984aa): this double screening for improved activity led to the identification of the enhanced multiple mutant UltraCjCas9. Our variant showed increased efficiency in comparison with CjCas9 WT and the rational designed mutant enCjCas9, while maintaining similar precision editing profile. Several modifications of the screening platform were applied to evolve another small Cas, the hypercompact CasΦ2 from phages: yeast and mammalian cells steps were optimized resulting in a platform suitable for the enhancement of almost inactive Cas nucleases. Our directed evolution approach to enhance Cas nucleases activity in eukaryotic cells enables the improvement of these enzymes directly within the chromatin environment, expanding the toolbox of available genome editors. Moreover, mutations identified applying this screening can give an insight into protein residues or interactions with key roles for efficiency in human cells.

Degree

thesis:*
Grantor dc:publisher
Università degli studi di Trento
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ruta, Giulia Vittoria
Contributors dc:contributor
  • Cereseto, Anna

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
  • license:Tutti i diritti riservati (All rights reserved)
  • license uri:iris.PRI01
Language dc:language
eng

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:iris.unitn.it:11572/406870

Chain of custody

source
Harvested from
Università degli Studi di Trento
Base URL
iris.unitn.it/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
related terms
citation

Ruta, Giulia Vittoria. A eukaryotic platform for the enhancement of Cas nucleases. Università degli studi di Trento, 2024. https://hdl.handle.net/11572/406870